ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF HYDROCHLOROTHIAZIDE, AMLODIPINE BESYLATE AND TELMISARTAN HYDROCHLORIDE IN MULTICOMPONENT TABLET DOSAGE FORM AND IN BIORELEVANT MEDIA (FASSIF) BY RP-HPLC TECHNIQUES

Authors

  • Madhukar A Bright Labs, Kothapet, Dilshuknagar, Hyderabad, Telangana
  • N. Kannappan Annamalai University
  • Mahendra Kumar Cb St. Mary’s College of Pharmacy, Secunderabad, Telangana

Keywords:

Hydrochlorothiazide (HTZ), Amlodipine besylate (AML) and Telmisartan hydrochloride (TLM), RP-HPLC, Validation, FaSSIF

Abstract

Objective: A simple, rapid, and precise reverse phase high performance liquid chromatographic (RP-HPLC) method for simultaneous analysis of Hydrochlorothiazide (HTZ), Amlodipine besylate (AML) and Telmisartan hydrochloride (TLM) in a tablet dosage form and in Biorelevant media has been developed and validated.

Methods: This method was performed with a thermosil C18 (4.6 × 100 mm i. d., 3.7 μm particle column with 40:60 (v/v) 20 mM potassium dihydrogen orthophosphate buffer: methanol as mobile phase at a flow rate of 1.0 ml/min. UV detection at 248 nm.

Results: By the method HTZ, AML and TLM were eluted with retention times of 1.823, 2.639, and 4.198 min, respectively. The method was continued and validated accordance with ICH guidelines. Validation revealed the method is rapid, specific, accurate, precise, reliable, and reproducible. Calibration curve plots were linear over the concentration ranges 6.25-100μg/mL for HTZ, 2.5-40μg/mL for AML, and 20-320μg/mL for TLM. Limits of detection (LOD) were 0.004, 0.0016, and 0.0128μg/ml and limits of quantification (LOQ) were 0.013, 0.0052, and 0.0416μg/mL for HTZ, AML and TLM respectively.

Conclusion: The statistical analysis was proves the method is suitable for the analysis of HTZ, AML and TLM as a bulk, in tablet dosage form and in biorelevant media without any interference from the excipients. It was also proved study for degradation kinetics of three drugs. It may be extended for its estimation in plasma and other biological fluids.

Downloads

Download data is not yet available.

References

Duarte JD, Cooper-DeHoff RM. "Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics". Expert Rev Cardiovasc Ther 2010;8(6):793-802.

WHO Model List of Essential Medicines. World Health Organization. Retrieved; 2014.

Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, Identification of novel functional inhibitors of acid sphingomyelinase. PLoS One 2011;6(8):e238-52.

Benson SC, Pershadsingh H, Ho C, Chittiboyina A, Desai P, Pravenec M, et al. "Identification of telmisartan as a unique angiotensin ii receptor antagonist with selective ppar –modulating activity". Hypertension 2004;43(5):993-1002.

V Vijayasree, C Pallavan, JVLN Seshagiri Rao. Development and Validation of an RP-HPLC Method for the estimation of hydrochlorothiazide in tablet dosage forms. IJPSR 2013;4(3):1052-5.

Richa Sah, Saahil Arora. Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: a potent Ca+2 channel blocker. J Adv Pharm Educ Res 2012;2(3):93-100.

Vijay Kumar R. Analytical method development and validation of telmisartan hydrochloride by RP-HPLC. J Sci Res Pharm 2012;1(2):100-1.

M Osman, H Abboud, MAAL–Mardini. Development and validation of RP-HPLC method for the estimation of telmisartan in bulk and pharmaceutical formulation. Int J Pharm Sci Rev Res 2013;21(1):34.

Boyka G Tsvetkova, Lily P Peikova. Development and validation of RP-HPLC method for simultaneous determination of Amlodipine Besylate and Hydrochlorothiazide in pharmaceutical dosage form. J Chem Pharm Res 2013;5(1):271-5.

Safeer K, Anbarasi B, N Senthil Kumar. Analytical method development and validation of amlodipine and hydrochlorothiazide in combined dosage form by RP-HPLC. Int J Chem Tech Res 2010;2(1):21-5.

Subhashini E, B Syama Sundhar. New analytical method development and validation for the simultaneous estimation of telmisartan and hydrochlorothiazide in bulk and tablet dosage form using RP-HPLC. Carib J Sci Tech 2014;2:519-29.

Ridhdhi S Sinojiya. Development and Validation of Rp-HPLC Method for the Simultaneous determination of telmisartan, amlodipine besylate & hydrochlorothiazide in a tablet dosage form. J Pharm Res 2012;5(8):4154-7.

Jabir Aboobacker O. Method development and validation of hydrochlorothiazide, amlodipine besylate and telmisartan in tablet dosage form by RP-HPLC Method. Res J Pharm Biol Chem Sci 2012;3(3):509-17.

S Nalwade. Rapid simultaneous determination of telmisartan, amlodipine besylate and hydrochlorothiazide in a combined poly pill dosage form by stability-indicating ultra performance liquid chromatography. Sci Pharm 2011;79:69-84.

Samya M. El-Gizawy. Development and validation of HPLC method for simultaneous determination of amlodipine, valsartan, hydrochlorothiazide in dosage form and spiked human plasma. Am J Anal Chem 2012;3:422-30.

Prathyusha W. Development and validation of a stability indicating RP-HPLC method for simultaneous estimation of aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide in bulk and pharmaceutical dosage forms. IOSR J Pharm Biol Sci 2014;9(1):114-23.

Vijay Kumar Rekulapally, Vinay U Rao. Stability Indicating RP-HPLC Method Development and validation for simultaneous estimation of aliskiren, amlodipine and hydrochlorthiazide in tablet dosage form. Int J Pharm Pharm Sci 2014;6(1):724-30.

Code Q2 (R1)-Text on Validation of Analytical Procedure Step-3 Consensus Guideline. ICH Harmonised Tripartite Guideline; 2005.

Code Q2A-Text on Validation of Analytical Procedure Step-3 Consensus Guideline. ICH Harmonised Tripartite Guideline; 1994.

Code Q2B-Validation of Analytical Procedure Methodology Step-4 Consensus Guideline. ICH Harmonised Tripartite Guideline; 1994.

International Conference on Harmonization. Photo stability testing of new drug substance and products Q1B. International Conference on Harmonization, IFPMA, Geneva; 1996.

Potale LV, Damle MC, Khodke AS, Bothara KG. A validated stability indicating HPTLC method for simultaneous estimation of Ramipril and telmisartan. Int J Pharm Sci Rev Res 2010;2:7.

Dongre VG, Shah SB, Karmuse PP, Phadke M, Jadhav VK. Simultaneous determination of metoprolol succinate and amlodipine besylate in pharmaceutical dosage form by HPLC. J Pharm Biomed Anal 2008;46(3):583-6.

Sudhakar P, Nirmala M, Moses Babu J, Vyas K, Madhusudan Reddy G, Vijaya Bhaskar B, et al. Identification and characterization of potential impurities of amlodipine maleate. J Pharm Biomed Anal 2006;40:605-13.

Lakshmi Narasimham YS, Barhate VD. Development and validation of stability indicating UPLC method for the simultaneous determination of beta-blockers and diuretic drugs in pharmaceutical dosage forms. J Chem Metrol 2010;4:1-20.

Naidu KR, Kale UN, Shingare MS. Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product. J Pharm Biomed Anal 2005;39:147-55.

Margareth Marques. Dissolution Media Simulating Fasted and Fed States. United States Pharmacopeia; 2004.

Published

01-01-2015

How to Cite

A, M., N. Kannappan, and M. K. Cb. “ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF HYDROCHLOROTHIAZIDE, AMLODIPINE BESYLATE AND TELMISARTAN HYDROCHLORIDE IN MULTICOMPONENT TABLET DOSAGE FORM AND IN BIORELEVANT MEDIA (FASSIF) BY RP-HPLC TECHNIQUES”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 1, Jan. 2015, pp. 218-25, https://journals.innovareacademics.in/index.php/ijpps/article/view/3500.

Issue

Section

Original Article(s)